baber/WOPTO huggingface dataset:
Patent NZ-587782-A (NZ)
Title: Wheelie bin with hollow section recessed rim for lifting
Inventor: VOSS THORSTEN
IPC: B65F1/14
Filed: 2010-09-03
Abstract: A rim 7, for a mobile garbage bin with a closed base and at least one container wall 4a defining an internal cavity, has a closed hollow section 28 defined at a lower edge by a base surface 29 extending outwardly from the container wall 4a. The base surface 29 is profiled to include a recess 36 which is defined at least partially by a first downwardly projecting flange formed in the base surface and facing towards the container wall 4a so as to form an inner edge of an enlarged lip portion.
Patent NZ-590510-A (NZ)
Title: Composition for transdermal delivery of cationic active agents
Inventor: SCHMITZ CHRISTOPH
IPC: A61K9/70
Filed: 2009-06-16
Abstract: Disclosed is a an iontophoretic transdermal delivery composition for at least one cationic active agent or a salt thereof comprising: said at least one cationic active agent or a salt thereof; at least one polyamine in the form of a polyamine salt, obtained by combining or reacting said polyamine with at least one organic acid; and water or an aqueous solvent mixture. Also disclosed is the use of the composition as an active substance reservoir of a transdermal patch.
Patent NZ-592013-A (NZ)
Title: Method for identifying and selecting drug candidates for combinatorial drug products
Inventor: PEDERSEN MIKKEL WANDAHL
IPC: C04B20/06
Filed: 2009-10-06
Abstract: Disclosed is a method for identifying and selecting chemical entities possessing or contributing to a functional effect in order to provide a mixture comprising at least 2 chemical entities showing a desired functional effect, said method comprising the steps of: a) providing n samples each comprising a chemical entity to be tested, wherein n is at least 3; b) mixing 2 or more of said n samples in all possible combinations in order to obtain a first set of mixtures to be tested; c) subjecting said first set of mixtures to a functional assay capable of measuring a functional parameter in order to identify chemical entities contributing to the functional effect; d) selecting m samples each comprising a chemical entity contributing to the functional effect in step c), wherein m is less than n; e) mixing two or more of said m samples in all possible combinations in order to obtain a second set of mixtures to be tested; f) subjecting said second set of mixtures to a functional assay capable of measuring a functional parameter in order to identify chemical entities contributing to the functional effect; and g) selecting a mixture possessing the desired functional effect. Further disclosed is a method for identifying and selecting an optimal stoichiometric ratio between chemical entities in a mixture comprising at least 2 chemical entities, said mixture showing a desired functional effect, the method comprising the steps of: aa) providing p samples each comprising one chemical entity to be present in the mixture; bb) diluting each of said p samples q times in order to obtain p series of samples each comprising the same chemical entity at different concentrations; cc) mixing 2 or more of the samples obtained in steps aa and bb in all possible combinations in order to obtain mixtures to be tested; dd) subjecting said mixtures to a functional assay capable of measuring a functional effect in order to identify the relationship between the measured functional effect and the concentration of the chemical entities in the mixture; and ee) selecting the mixture possessing the desired functional effect.
Patent NZ-594836-A (NZ)
Title: A particle beam irradiation apparatus for charged particle cancer theapy
Inventor: BALAKIN VLADIMIR EGOROVICH
IPC: A61N5/10
Filed: 2009-03-04
Abstract: 594836 Disclosed is a particle beam irradiation apparatus for charged particle cancer therapy of a tumor of a patient. Included are a synchrotron (130) which accelerates a charged particle beam and a respiration sensor generating a respiration signal such that the respiration signal monitors a breathing cycle of the patient. A rotatable platform holds the patient rotates through about three hundred sixty degrees during an irradiation period of the patient. The synchrotron (130) uses the respiration signal to deliver the charged particle beam to the tumor at a set point in the breathing cycle. The delivery of the charged particle beam at the set point of the breathing cycle occurs in greater than five rotation positions of the rotatable platform.
Patent NZ-595487-A (NZ)
Title: Safety structure for a railway line
Inventor: BIESBROUCK GERARDUS MAJELLA
IPC: E01B26/00
Filed: 2010-03-29
Abstract: 595487 Safety structure for shielding a railway line comprising a fencing which is upright in the position of use and provided with supports (10) which are horizontal in the position of use. The supports (10) can be connected to a rail (3) having a web (25) part by one end (11), which end (11) comprises a permanent magnet (15) with a free surface (20) for contacting a rail (3). This end (11) comprises a head end part (18) having the magnet (15), the head end part (18) being arranged to contact the web part (25) of a rail (3) with a contact surface. The contact surface includes the free surface (20) of the magnet (15), the magnet (15) being provided for absorbing tensile forces exerted in a direction at right angles to the contact surface. The head end part (18) comprising the magnet (11) is the only part of the support (10) which is in contact with the rail (3).
Patent NZ-596346-A (NZ)
Title: Improvements in, or relating to, multi currency pricing and network transaction services
Inventor: SHARMA SUNIL
IPC: G06F17/30
Filed: 2011-11-10
Abstract: Disclosed are a method, system and device for multi-currency pricing over a network. Information is provided to a first computer device in a first geographic location connected to the network and identifying data of the first computer device is obtained. The first geographic location is detected from the identifying data, a first currency is chosen based on the first geographic location and an equivalent in said first currency to at least one price in the information is calculated. The information provided to the first computer device is in the first currency, which is the local currency of the first geographic location.
Patent NZ-596837-A (NZ)
Title: Anti-vegf antibodies and their uses
Inventor: HARDING FIONA
IPC: A61P35/00
Filed: 2010-06-17
Abstract: 596837 Disclosed is an anti-VEGF antibody or an anti-VEGF binding fragment thereof, which has greater affinity to human VEGF than bevacizumab and comprises CDRs having amino acid sequences corresponding to SEQ ID NO: 3 (CDR-H1), SEQ ID NO:4 (CDR-H2), SEQ ID NO:5 (CDR-H3), SEQ ID NO:6 (CDR-L1), SEQ ID NO:7 (CDR-L2) and SEQ ID NO:8 (CDR-L3), wherein CDR-HI includes the substitution N31F, wherein the six CDRs altogether have up to 17 amino acid substitutions as compared to CDR sequences of the antibody bevacizumab, and wherein CDR-H1 in said anti-VEGF antibody or anti-VEGF binding fragment thereof does not consist of a CDR-H1 sequence set forth in Tables 12-1 to 12-9.
Patent NZ-598212-A (NZ)
Title: Locking device with integrated circuit board
Inventor: ZIMMER TODD C
IPC: E05B17/22
Filed: 2010-08-20
Abstract: 598212 A locking device is disclosed comprising a lock mechanism having a rotating lock component to be monitored, a circuit board mounted to the exterior of the lock mechanism, a magnet mounted in an opening of the rotating lock component and at least one sensor. The rotating lock component is movable only manually. The circuit board has a perimeter shaped to fit the circuit board to the exterior of the lock mechanism and a component mounting surface of the circuit board is located in close proximity to the rotating lock component when the circuit board is mounted to the exterior of the lock mechanism. The at least one sensor is mounted to the component mounting surface of the circuit board such that the sensor is located adjacent to the rotating lock component to be monitored having the magnet mounted therein, whereby as the rotating lock component is manually rotated the magnet moves closer to the sensor to detect manual operation of the lock mechanism. A locking device is disclosed comprising a cylindrical lock having a bearing and a spindle rotating within the bearing; a magnet mounted in an opening of the spindle and rotating therewith; a circuit board mounted to the exterior of the cylindrical lock and a non-contact sensor responsive to the magnet. The cylindrical lock has an outer radius defining an outer surface of the cylindrical lock and a bearing radius defining an outer surface of the bearing. The circuit board includes a component mounting surface and a concave shape defined by a perimeter having a curved outer edge having a radius corresponding to the outer radius of the cylindrical lock; and a curved inner edge having a radius corresponding to the bearing radius. The on-contact sensor is mounted on the circuit board and positioned in close proximity to the spindle to detect the magnet when the spindle is rotated via manual operation to a defined position whereby as the spindle is manually rotated the magnet moves closer to the non-contact sensor to detect manual manipulation of the cylindrical lock.
Patent NZ-598267-A (NZ)
Title: Modification of plant and seed development and plant responses to stresses and stimuli (6)
Inventor: SPANGENBERG GERMAN
IPC: C07K14/415
Filed: 2002-05-07
Abstract: 598267 Disclosed are substantially purified or isolated stress responsive protein (A22) polypeptides from ryegrass (Lolium) species.
Patent NZ-598634-A (NZ)
Title: Method for separating sialyllactose material
Inventor: SOGAME HITOMI
IPC: A23C9/142
Filed: 2010-09-27
Abstract: Disclosed is a method of obtaining a sialyllactose material from a milk material, the method comprising: a)removing proteins from the milk material to obtain a protein-free liquid; b)adjusting the pH of the protein-free liquid to obtain a pH-adjusted liquid; and c)concentrating the pH-adjusted liquid by an ultrafiltration (UF) membrane, wherein when skim milk is the milk material the pH of the protein-free liquid is adjusted to 5.6 to 6.6, and when whey is the milk material the pH of the protein-free liquid is adjusted to 3.6 to 5.5.
Patent NZ-600612-A (NZ)
Title: Apparatus for transferring load
Inventor: SINGH KALVIN JIT
IPC: A01B59/042
Filed: 2010-08-27
Abstract: Use of a load imparted by a towed implement on a towing vehicle to pull the front wheels of the towing vehicle into contact with the ground via a linkage between the front end of the towed implement and the front end of the towing vehicle at a point positioned leading the front wheel axle of the vehicle. The linkage passes below the front wheel axle and includes a shock absorber.
Patent NZ-601854-A (NZ)
Title: Fastenings and other components for use with treated timber
Inventor: GONG YIZHENG
IPC: C23C18/31
Filed: 2012-08-15
Abstract: A method of forming and using a steel component comprises subjecting the component to hot-dip galvanising in order to prepare a zinc coating on the component, coating the zinc coated steel component with a polymer coating applied directly onto the zinc coating to provide the component with a resistance to corrosion from copper based preservative in treated timber, and using the copper resistant zinc coated steel component in direct contact with timber treated with a copper-based preservative. The polymer coating is a thermosetting polymer in the form of an epoxy resin.
Patent NZ-608077-A (NZ)
Title: Rigid hull gas-can buoys with variable buoyancy
Inventor: YEMINGTON CHARLES R
IPC: E21B17/01
Filed: 2011-09-09
Abstract: An apparatus and method directed to a variable buoyancy gas-can buoyancy module or buoy having a flexible barrier (20) between a variable volume gas chamber (19) in the gas-can hull (10) and water in the hull. More specifically, the apparatus is directed to a variable buoyancy module for a Self Supporting Riser (SSR) wherein the tension in the SSR may be increased/decreased by increasing/decreasing the variable volume of a chamber formed by a flexible liner that provides a barrier between the variable volume gas chamber in the gas-can hull and water.
Patent NZ-609920-A (NZ)
Title: Inhaler
Inventor: MELINIOTIS ANDREAS
IPC: A61M15/00
Filed: 2011-11-25
Abstract: An inhaler comprising a housing (11A) defining a chamber to receive a strip having a plurality of blisters each containing a dose of medicament for inhalation by a user is disclosed. It is common for dry powder formulations to be pre-packaged in individual doses, usually in the form of capsules or blisters which each contain a single dose of the powder which has been accurately and consistently measured. It is advantageous for the inhaler to be capable of holding a number of doses. Therefore, many conventional devices include means for storing a number of blisters each containing an individual dose of medicament. When a dose is to be inhaled, an indexing mechanism moves a previously emptied blister away from the opening mechanism so that a fresh one is moved into a position ready to be opened for inhalation of its contents. The empty blister now takes up space in the inhaler making it bulkier than necessary. The inhaler has an actuating lever (14) and a blister strip drive member rotatably mounted in the chamber to sequentially move each blister into a blister opening position. The blister strip drive member and the actuating lever comprise a drive gear (16) and a drive gear element (28), cooperate to effect rotation of the blister strip drive member in response to rotation of the actuating lever. The drive gear and drive gear element are disposed on the outside of the housing remote from the chamber. The blister strip drive member is positioned relative to a wall such that the distance between the hub and the wall is less than the height of a blister cavity such that onward rotation of a blister strip drive wheel causes a blister cavity to be at least partially squashed or sandwiched between the hub and said wall. The advantage of at least partially crushing the empty blister cavities is that they then take up less space when coiled within the used blister chamber of the device as the coiled strip has a smaller diameter. Furthermore, a natural curvature is imparted to the strip, both as a result of being fed around the blister drive wheel and also as a result of the crushing of the blister cavities. This encourages the used portion of the strip to coil more readily.
Patent NZ-618935-A (NZ)
Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
Inventor: CHEN HUAN-MAO
IPC: A61K35/742
Filed: 2011-08-04
Abstract: 618935 Disclosed is a barrier device adapted to be pivotally mounted on one of left and right sides of
Patent NZ-702081-A (NZ)
Title: Method for converting a sugar to furfuryl alcohol
Inventor: MEDOFF MARSHALL
IPC: C13K13/00
Filed: 2013-07-03
Abstract: A method for converting a sugar to furfuryl alcohol, the method comprising; chemically converting xylose to furfural and then reducing furfural to furfuryl alcohol, the xylose being obtained by treating biomass with irradiation to reduce the recalcitrance of the biomass and saccharification of the biomass with one or more enzymes to produce sugars including xylose and glucose, the sugars having been subjected to fermentation to ferment sugars other than xylose to a greater degree than xylose and wherein the xylose has been isolated from the glucose by simulated moving bed chromatography.
Patent NZ-720345-A (NZ)
Title: Improvements in and relating to beehives
Inventor: HAROLD BRUCE CLOW
IPC: A01K53/00
Filed: 2016-05-19
Abstract: Conventional feeder trays generally access syrup via a central projection and associated apertures. The present invention provides a feeder tray for a bee hive which has partitioned access feeders on each corner. The present invention therefore enables bees to access syrup via feeder at the access feeders even when syrup levels are only present at one end of the tray due to the slope of the hive.
Patent NZ-721231-A (NZ)
Title: Cushion for patient interface
Inventor: HITCHCOCK ROBIN GARTH
IPC: A61M16/06
Filed: 2006-01-12
Abstract: A cushion (10) for a patient interface that delivers breathable gas to a patient, the cushion defining part of a cavity which receives at least part of the nose and / or mouth of the patient. The cushion includes a base wall, a membrane (32) adapted to form a seal on the patient’s face and a support structure (30) that extends from an inner surface of the cushion into the cavity. The cushion includes a nasal bridge region, a pair of side of nose regions, a pair of upper cheek regions, a pair of lower cheek regions, and a chin region. The support provides support to the pair of side of nose regions of the cushion, the support structure being absent in the chin region of the cushion. At least a portion of the membrane is thinner than at least a portion of the support structure. At least a portion of the membrane in the pair of lower cheek regions is thicker than at least a portion of the membrane in the nasal bridge region.
Patent NZ-723484-A (NZ)
Title: Device and method for continuous virus inactivation
Inventor: LOBEDANN MARTIN
IPC: A61L2/10
Filed: 2015-03-06
Abstract: Discloses is a process for the continuous virus inactivation of a product stream, which comprises the following steps: a) provision of the product stream to be inactivated, b) introduction of the product stream into an inlet of a tube or hose having an inlet and an outlet, where the tube or the hose is curved and/or helically coiled with a number n of windings around a coil axis h and has one or more changes in direction and/or bends in the coil axis having an angle α of from 45° to 180° to alter the direction of action of the normals of a centrifugal force, where an apparatus is formed by the described tube or hose and said apparatus has a Dean number ≥2 and a torsion parameter > 100, c) flow of the product stream through the tube or the hose under virus-inactivating conditions and d) exit from the tube or the hose through the outlet and wherein the pH of the product stream in step a) is set to a value of ≤ 4 and wherein the pH is set to ≥ 5 after step d) in order to stop virus inactivation. The provision of bends in the coil axis narrows the residence time distribution compared to those of straight helix tubes.
Patent NZ-728658-A (NZ)
Title: Custom nutritional supplement composition production system and method
Inventor: NORTJÉ BERNARD ETIENNE
IPC: A23L33/10
Filed: 2015-07-07
Abstract: The invention provides a system which implements a method of altering the flavour, stability, consistency, texture and colour of the a custom nutritional supplement composition containing nutritional supplement ingredients selected by a user of the system, said method including addition of specific additives in specific quantities to a custom nutritional supplement composition recipe, which additives and quantities are selected through the retrieval of data stored on a computer system which data has correlated the combinations of nutritional supplement ingredients, the additives, and their relative quantities. The system extends to an automated method of preparing a custom nutritional supplement composition, said method Including preparing one or more master batches or base mixes and add-mixes including one or more nutritional supplement ingredients and/or one or more additives in predetermined ratios, and in response to a user custom nutritional supplement composition product request, combining calculated or selected quantities of one or more master batches including base mixes and/or add-mixes, one or more additives, and/or one or more nutritional supplement ingredients thereby to obtain a palatable, stabilised, custom nutritional supplement composition product having a desired flavour, colour and consistency, or any other sensory characteristics, while reducing the number of components required to be blended to achieve same.
Patent NZ-731779-A (NZ)
Title: Novel polymeric hgh prodrugs
Inventor: RAU HARALD
IPC: A61P43/00
Filed: 2015-11-17
Abstract: The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.
Patent NZ-741482-A (NZ)
Title: Shade for animals
Inventor: PAT MCCARTEN
IPC: E04H15/58
Filed: 2019-07-23
Abstract: A portable shade or shelter for animals includes plural assemblies of vertical posts and rafters, each vertical post of which can be strapped to adjacent posts of a paddock fence. The shelter is constructed so that it remains strong and steady in high wind conditions. In each assembly the cantilevered rafters are attached to the vertical posts by joints so that the rafters can be readily dismantled from the vertical posts. The shade cloth is stretched between adjacent rafters. A compression brace between the vertical post and the rafter is provided and a tension rope can be attached between the distal end of the rafter and the top extension piece of the post to support the rafter. Diagonal tension ropes can be provided between the respective end assemblies of the shelter and a further post on the same side of the paddock fence as the end assembly.
Patent NZ-741530-A (NZ)
Title: Milking installation, milking equipment and teat cup liner, and associated operating method
Inventor: FISCHER FRIEDRICH
IPC: A01J7/04
Filed: 2016-09-06
Abstract: The invention relates to milking equipment (10) comprising at least one, in particular four teat cups (12), wherein each teat cup (12) has a cup housing (14) and a teat cup liner (16), accommodated in the cup housing (14), having a head region (18) and a suction region (20). At the cup bottom (22) or at the end of the suction region (20) of the teat cup liner (16) there is a connection (26) for a milk tube (24). It is proposed that a mouth portion (32) of a sterile-air pressure line (34) be arranged in the head region (18) of the teat cup liner (16), sterile air with a volumetric flow rate (Vs) greater than a fluid extraction volumetric flow rate (Vm) at the milk tube (24) being passable through said sterile-air pressure line (34), such that a sterile-air overlay (84) is established in the head region (18) of the teat cup liner (16). In secondary aspects, the invention relates to a milking installation (60), to a teat cup liner (16) for the milking equipment (10) and to a milking method with sterile-air overlay. The invention prevents milked milk from being contaminated by contaminants and germs in the stable air, and so increased durability of untreated raw milk can be achieved.
Patent NZ-753549-A (NZ)
Title: Combination comprising benzoheterocyclic compound and androgen receptor pathway modulator, application thereof and treatment method
Inventor: GE CHUANSHENG
IPC: A61K31/365
Filed: 2017-12-15
Abstract: Provided are a composition, an application thereof and a treatment method. The composition comprises a benzoheterocyclic compound represented by general formula (I), one or more from among a pharmaceutically acceptable salt thereof, a solvate, a crystal form, a cocrystal, a stereoisomer, an isotope compound, a metabolite and a prodrug, and an androgen receptor pathway modulator and/or a hormone drug. The composition and treatment method may effectively inhibit the growth of prostate cancer cells.